| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q3 2021 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TR | 8 | Q3 2023 | 38.6% |
| VANGUARD INDEX FDS | 8 | Q3 2023 | 26.4% |
| SPDR INDEX SHS FDS | 8 | Q3 2023 | 13.3% |
| ISHARES TR | 6 | Q1 2023 | 23.3% |
| ISHARES TR | 6 | Q1 2023 | 6.0% |
| ISHARES TR | 5 | Q1 2023 | 4.3% |
| ISHARES TR | 4 | Q3 2022 | 5.6% |
| ISHARES TR | 3 | Q3 2022 | 12.7% |
| ISHARES TR | 3 | Q2 2022 | 11.0% |
| ISHARES TR | 2 | Q3 2023 | 20.0% |
View Hackensack Meridian Health, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-08 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-11 |
View Hackensack Meridian Health, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.